loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 807f988e 117b 4497 934d 73aa78baac71 Applno 203469 Form Tablet Oral Dosage Eq 15mg Base - Drug Product Composition: Ponatinib

    Menu

    Ponatinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 84,358Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 203469 / DOSAGE - TABLET;ORAL - EQ 15MG BASE

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ponatinib hydrochloride(UNII: 96R6PU3D8J)
    (ponatinib - UNII:4340891KFS)     		ponatinib30mg | 45mg | 15mg

    Inactive Ingredients

    Ingredient Name
    ARIAD Pharmaceuticals, Inc.
    lactose monohydrate(EWQ57Q8I5X)
    magnesium stearate(70097M6I30)
    microcrystalline cellulose(OP1R32D61U)
    silicon dioxide(ETJ7Z6XBU4)
    sodium starch glycolate type B potato(27NA468985)